Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillance

Abstract Introduction Afghanistan added ROTARIX to the routine national immunization programme in 2018. We aimed to estimate the cost-effectiveness and benefit-risk of ROTARIX and compare its continued use with other rotavirus vaccines that could be used in the future. Methods We used a static cohor...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Palwasha Anwari, Frédéric Debellut, Sardar Parwiz, Clint Pecenka, Andrew Clark
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-07-01
Serie:	BMC Health Services Research
Soggetti:	Rotavirus vaccine Cost-utility Cost-effectiveness Benefit-risk Rotavirus gastroenteritis Afghanistan
Accesso online:	https://doi.org/10.1186/s12913-025-12885-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!